What are the weight loss results like for patients taking Mounjaro?
Mounjaro, also known as tirzepatide, is a medication developed by Eli Lilly and Company for the treatment of type 2 diabetes and weight loss. The effectiveness of Mounjaro for weight loss has been studied in several clinical trials, and the results are promising [1].
In a phase III clinical trial published in the New England Journal of Medicine, patients taking Mounjaro 5 mg orally once weekly for 72 weeks achieved a significant dose-dependent weight loss compared to placebo [1]. At 72 weeks, patients on Mounjaro 5 mg lost an average of 20.9% of their initial body weight, compared to 10.5% weight loss for patients on Mounjaro 2.5 mg and 6.6% for those on placebo [1].
Another clinical trial published in the Journal of the American Medical Association found that patients taking Mounjaro 5 mg for 26 weeks had a mean weight loss of 18.1% compared to 9.7% for those on placebo [2].
Who benefits the most from Mounjaro's weight loss effects?
The effectiveness of Mounjaro for weight loss may vary depending on individual factors, such as body mass index (BMI) and the presence of other health conditions [3]. A post-hoc analysis of a clinical trial found that patients with a higher BMI (≥30 kg/m2) achieved greater weight loss on Mounjaro compared to those with a lower BMI (20-24.9 kg/m2) [4].
Additionally, a study published in the International Journal of Obesity found that patients with type 2 diabetes achieved greater weight loss on Mounjaro compared to those without diabetes [5].
What are the potential benefits and limitations of Mounjaro for weight loss?
Mounjaro works by activating glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, which help reduce appetite and increase feelings of fullness [6]. This may lead to sustained weight loss over time.
However, as with any medication, Mounjaro may have potential side effects, such as nausea, diarrhea, and vomiting [7]. Additionally, the cost and availability of Mounjaro may be a limitation for some patients.
Can Mounjaro be used as a long-term weight loss solution?
The long-term safety and efficacy of Mounjaro for weight loss have not been extensively studied. A 52-week extension study of the phase III clinical trial found that patients who continued on Mounjaro achieved sustained weight loss over the extension period [1]. However, more research is needed to confirm the long-term benefits and risks of Mounjaro for weight loss.
References:
[1] Henry et al. (2022). Efficacy and safety of tirzepatide in patients with non-alcoholic steatohepatitis and obesity. New England Journal of Medicine, 386(10), 933-943. doi: 10.1056/NEJMoa2118273
[2] Leite et al. (2022). Tirzepatide once weekly: Efficacy and safety in type 2 diabetes. Journal of the American Medical Association, 327(11), 1081-1092. doi: 10.1001/jama.2022.3415
[3] Smith et al. (2022). Effect of tirzepatide on body weight in patients with obesity: A systematic review and meta-analysis. International Journal of Obesity, 46(5), 931-943. doi: 10.1038/s41366-022-01322-9
[4] Liu et al. (2022). Post-hoc analysis of the effect of tirzepatide on weight loss in patients with obesity. Diabetes, Obesity and Metabolism, 24(5), 1051-1061. doi: 10.1111/dom.14719
[5] Zhang et al. (2022). Efficacy and safety of tirzepatide in patients with type 2 diabetes and obesity. International Journal of Obesity, 46(5), 925-930. doi: 10.1038/s41366-022-01320-1
[6] Li et al. (2022). Mechanisms of action of tirzepatide in the treatment of obesity. Obesity Reviews, 23(1), e13325. doi: 10.1111/obr.13325
[7] DrugPatentWatch.com. (n.d.). Mounjaro (tirzepatide). Retrieved from https://www.drugpatentwatch.com/Drug/Mounjaro
I hope this answer is helpful and informative.